Nogués, X.
Nolla, J. M.
Casado, E.
Jódar, E.
Muñoz-Torres, M.
Quesada-Gómez, J. M.
Canals, L.
Balcells, M.
Lizán, L.
Funding for this research was provided by:
Amgen
Article History
Received: 1 June 2017
Accepted: 8 November 2017
First Online: 24 November 2017
Compliance with ethical standards
:
: The project received financial support from Amgen S.A. to conduct the study. LC and MB work at Amgen S.A. and hold stock in Amgen. LL works at a Life Science Boutique that received funding from Amgen S.A. to coordinate and conduct the study and to write up the manuscript. MMT has received research grants from UCB and MSD; is a consultant for Amgen, Lilly, and UCB; and speakers’ bureau member for Amgen and Lilly. EJ has received research grants from Amgen, Lilly, and MSD and consulting fees from Amgen, UCB, and Lilly. XN has received research grants from Lilly and Amgen; is a consultant for Lilly and Amgen; and speakers’ bureau member for Lilly, Amgen, and MSD. JMN is a consultant for Abbvie, Amgen, BMS, Gebro, Lilly, MSD, Roche, Sandoz, and UCB and speakers’ bureau member for Abbvie, Amgen, BMS, Gebro, Lilly, MSD, Roche, and UCB. JMQ has received research grants from Amgen, Lilly, FIS Carlos III, RETICEF, and Intensification of Investigation Junta de Andalucía; is a consultant for Amgen, MSD, Italfarmaco, and FAES; and speakers’ bureau member for Amgen, MSD, Italfarmaco, and FAES. EC has participated in the speakers’ bureau for Amgen, Lilly, MSD, FAES, and Rubió. All authors declare that all the results presented in the manuscript are the true expression of findings and there has been no interference in respondents’ free communication and dissemination.